KCNH2 was significantly differentially expressed in samples grouped by CNV type in 10 tumours (GBMLGG, LGG, cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), BRCA, STES, SARC, KIRP, mesothelioma (MESO), PAAD, OV) (Fig. 5B). Here, KCNH2 is linked to mesothelioma.